Terms: = Colorectal cancer AND FOXP3, AIID, DIETER, IPEX, JM2, PIDX, XPID
411 results:
1. Interleukin-17 directly stimulates tumor infiltrating Tregs to prevent cancer development.
Theune WC; Chen J; Theune EV; Ye X; Ménoret A; Vella AT; Wang K
Front Immunol; 2024; 15():1408710. PubMed ID: 38947320
[TBL] [Abstract] [Full Text] [Related]
2. Analysis of tumor microenvironment alterations in partially responsive rectal cancer patients treated with neoadjuvant chemoradiotherapy.
Chen H; Zhang JH; Hao Q; Wu XL; Guo JX; Huang CX; Zhang J; Xing GS; An ZL; Ling Y; Zhao JG; Bao YN
Int J Colorectal Dis; 2024 Jun; 39(1):99. PubMed ID: 38926205
[TBL] [Abstract] [Full Text] [Related]
3. Tumor Infiltrating Effector Regulatory T Cells Express VEGF Receptor 2 in Patients With colorectal cancer.
Tsumuraya H; Mimura K; Nakajima S; Hanayama H; Matsuishi A; Okayama H; Fukai S; Ito M; Ashizawa M; Chida S; Onozawa H; Sakamoto W; Saito M; Saze Z; Momma T; Kono K
Anticancer Res; 2024 Jul; 44(7):2933-2941. PubMed ID: 38925828
[TBL] [Abstract] [Full Text] [Related]
4. Characterisation of colorectal cancer by hierarchical clustering analyses for five stroma-related markers.
Ito S; Koshino A; Wang C; Otani T; Komura M; Ueki A; Kato S; Takahashi H; Ebi M; Ogasawara N; Tsuzuki T; Kasai K; Kasugai K; Takiguchi S; Takahashi S; Inaguma S
J Pathol Clin Res; 2024 Jul; 10(4):e12386. PubMed ID: 38890810
[TBL] [Abstract] [Full Text] [Related]
5. LINC00982-encoded protein PRDM16-DT regulates
Hu HF; Han L; Fu JY; He X; Tan JF; Chen QP; Han JR; He QY
Theranostics; 2024; 14(8):3317-3338. PubMed ID: 38855188
[TBL] [Abstract] [Full Text] [Related]
6. Multiomics-based molecular subtyping based on the commensal microbiome predicts molecular characteristics and the therapeutic response in breast cancer.
Qin W; Li J; Gao N; Kong X; Guo L; Chen Y; Huang L; Chen X; Qi F
Mol Cancer; 2024 May; 23(1):99. PubMed ID: 38730464
[TBL] [Abstract] [Full Text] [Related]
7. Exploring the clinical significance of IL-38 correlation with PD-1, CTLA-4, and foxp3 in colorectal cancer draining lymph nodes.
Yuan L; Tan Z; Huang J; Chen F; Hambly BD; Bao S; Tao K
Front Immunol; 2024; 15():1384548. PubMed ID: 38533512
[TBL] [Abstract] [Full Text] [Related]
8. PD-L1 Expression in colorectal Carcinoma Correlates with the Immune Microenvironment.
Shahin M; Patra S; Purkait S; Kar M; Das Majumdar SK; Mishra TS; Samal SC; Nayak HK
J Gastrointest Cancer; 2024 Jun; 55(2):940-949. PubMed ID: 38530597
[TBL] [Abstract] [Full Text] [Related]
9. Association of preoperative aspartate aminotransferase to platelet ratio index with outcomes and tumour microenvironment among colorectal cancer with liver metastases.
Chen Q; Deng Y; Li Y; Chen J; Zhang R; Yang L; Guo R; Xing B; Ding P; Cai J; Zhao H
Cancer Lett; 2024 Apr; 588():216778. PubMed ID: 38458593
[TBL] [Abstract] [Full Text] [Related]
10. Lactate modulates RNA splicing to promote CTLA-4 expression in tumor-infiltrating regulatory T cells.
Ding R; Yu X; Hu Z; Dong Y; Huang H; Zhang Y; Han Q; Ni ZY; Zhao R; Ye Y; Zou Q
Immunity; 2024 Mar; 57(3):528-540.e6. PubMed ID: 38417442
[TBL] [Abstract] [Full Text] [Related]
11. Evaluating CD4 and foxp3 mRNA Expression in Tissue Specimens of Celiac Disease and colorectal cancer Patients.
Asri N; Nazemalhosseini Mojarad E; Taleghani MY; Houri H; Saeedi Niasar M; Rezaei-Tavirani M; Jahani-Sherafat S; Shahbazkhani A; Nikzamir A; Ehsani Ardakani MJ; Khodadost M; Rostami-Nejad M
Asian Pac J Cancer Prev; 2024 Feb; 25(2):647-652. PubMed ID: 38415552
[TBL] [Abstract] [Full Text] [Related]
12. Location matters: spatial dynamics of tumor-infiltrating T cell subsets is prognostic in colon cancer.
Zhu H; Roelands J; Ahmed EI; Stouten I; Hoorntje R; van Vlierberghe RLP; Ijsselsteijn ME; Lei X; de Miranda NFCC; Tollenaar RAEM; Vahrmeijer AL; Bedognetti D; Hendrickx WRL; Kuppen PJK
Front Immunol; 2024; 15():1293618. PubMed ID: 38375478
[TBL] [Abstract] [Full Text] [Related]
13. Preclinical efficacy of carfilzomib in BRAF-mutant colorectal cancer models.
Maione F; Oddo D; Galvagno F; Falcomatà C; Pandini M; Macagno M; Pessei V; Barault L; Gigliotti C; Mira A; Corti G; Lamba S; Riganti C; Castella B; Massaia M; Rad R; Saur D; Bardelli A; Di Nicolantonio F
Mol Oncol; 2024 Jun; 18(6):1552-1570. PubMed ID: 38348572
[TBL] [Abstract] [Full Text] [Related]
14. FSTL3 promotes tumor immune evasion and attenuates response to anti-PD1 therapy by stabilizing c-Myc in colorectal cancer.
Li H; Zheng N; Guo A; Tang W; Li M; Cao Y; Ma X; Cao H; Ma Y; Wang H; Zhao S
Cell Death Dis; 2024 Feb; 15(2):107. PubMed ID: 38302412
[TBL] [Abstract] [Full Text] [Related]
15. Multiplex analysis of intratumoural immune infiltrate and prognosis in patients with stage II-III colorectal cancer from the SCOT and QUASAR 2 trials: a retrospective analysis.
Frei AL; McGuigan A; Sinha RRAK; Jabbar F; Gneo L; Tomasevic T; Harkin A; Iveson T; Saunders MP; Oien KA; Maka N; Pezzella F; Campo L; Browne M; Glaire M; Kildal W; Danielsen HE; Hay J; Edwards J; Sansom O; Kelly C; Tomlinson I; Kerr R; Kerr D; Domingo E; ; Church DN; Koelzer VH
Lancet Oncol; 2024 Feb; 25(2):198-211. PubMed ID: 38301689
[TBL] [Abstract] [Full Text] [Related]
16. IL-10 dampens antitumor immunity and promotes liver metastasis via PD-L1 induction.
Shiri AM; Zhang T; Bedke T; Zazara DE; Zhao L; Lücke J; Sabihi M; Fazio A; Zhang S; Tauriello DVF; Batlle E; Steglich B; Kempski J; Agalioti T; Nawrocki M; Xu Y; Riecken K; Liebold I; Brockmann L; Konczalla L; Bosurgi L; Mercanoglu B; Seeger P; Küsters N; Lykoudis PM; Heumann A; Arck PC; Fehse B; Busch P; Grotelüschen R; Mann O; Izbicki JR; Hackert T; Flavell RA; Gagliani N; Giannou AD; Huber S
J Hepatol; 2024 Apr; 80(4):634-644. PubMed ID: 38160941
[TBL] [Abstract] [Full Text] [Related]
17. Integrin-linked kinase expression in myeloid cells promotes colon tumorigenesis.
Ahmed AU; Almasabi S; Firestein R; Williams BRG
Front Immunol; 2023; 14():1270194. PubMed ID: 38077324
[TBL] [Abstract] [Full Text] [Related]
18. RNA Expression-Based Analysis to Predict Response in Patients with Metastatic Mismatch Repair Proficient colorectal cancer Treated with Regorafenib and Nivolumab.
Miao R; Kim DW; Yu J; Malafa M; Mehta R; Strosberg J; Imanirad I; Iyer S; Uhlik M; Benjamin L; Kim R
Oncology; 2024; 102(7):549-555. PubMed ID: 38061339
[TBL] [Abstract] [Full Text] [Related]
19. foxp3-regulated lncRNA NONHSAT136151 promotes colorectal cancer progression by disrupting QKI interaction with target mRNAs.
Huang H; Liang X; Wu W; Yuan T; Chen Z; Wang L; Wu Z; Zhang T; Yang K; Wen K
J Cell Mol Med; 2024 Jan; 28(2):e18068. PubMed ID: 38041531
[TBL] [Abstract] [Full Text] [Related]
20. Opposing roles by KRAS and BRAF mutation on immune cell infiltration in colorectal cancer - possible implications for immunotherapy.
Edin S; Gylling B; Li X; Stenberg Å; Löfgren-Burström A; Zingmark C; van Guelpen B; Ljuslinder I; Ling A; Palmqvist R
Br J Cancer; 2024 Jan; 130(1):143-150. PubMed ID: 38040818
[TBL] [Abstract] [Full Text] [Related]
[Next]
